|
An adverse event was reported from an integrity pmcf study involving the shoulder.The subject reported continued stiffness and limited motion in the operated shoulder, and a glenohumeral injection was performed.The event began on (b)(6) 2026 and was ongoing at the time of reporting, with no end date available.Symptoms were mild, the event was not serious, and no serious health threat was reported.The safety event was classified as an adverse event, device classification was not applicable, causality was assessed as possible/uncertain, and the outcome was reported as resolving.This case will updated with any new relevant information.
|